 | • レポートコード：GIR-2104Z00930 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗腫瘍剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗腫瘍剤の種類別市場規模（化学療法、標的療法、免疫療法、内分泌療法（生物学的療法）、その他）、用途別市場規模（血液がん、乳がん、胃腸がん、前立腺がん、呼吸器/肺がん、その他がん）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗腫瘍剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche、Novartis、Celgene、Bristol-Myers Squibb、Amgen、Johnson & Johnson、Pfizer、Takeda、Eli Lilly、AstraZeneca、Astellas、Merck & Co.、Sanofi、Bayer、Biogen Idec、Eisai、Teva、Otsuka、Merck KGaA、Ipsen、AbbVie、Gilead Sciences ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：化学療法、標的療法、免疫療法、内分泌療法（生物学的療法）、その他 ・用途別分析2016年-2026年：血液がん、乳がん、胃腸がん、前立腺がん、呼吸器/肺がん、その他がん ・抗腫瘍剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗腫瘍剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗腫瘍剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗腫瘍剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗腫瘍剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anti – Neoplastic Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anti – Neoplastic Agents size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Anti – Neoplastic Agents market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Anti – Neoplastic Agents market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Market segment by Application can be divided into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
The key market players for global Anti – Neoplastic Agents market are listed below:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Anti – Neoplastic Agents Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti – Neoplastic Agents Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy (Biologic Therapy)
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti – Neoplastic Agents Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Other Cancers
1.4 Global Anti – Neoplastic Agents Market Size & Forecast
1.4.1 Global Anti – Neoplastic Agents Sales in Value (2016-2026))
1.4.2 Global Anti – Neoplastic Agents Sales in Volume (2016-2026)
1.4.3 Global Anti – Neoplastic Agents Price by Type (2016-2026) & (USD/Unit)
1.5 Global Anti – Neoplastic Agents Production Capacity Analysis
1.5.1 Global Anti – Neoplastic Agents Total Production Capacity (2016-2026)
1.5.2 Global Anti – Neoplastic Agents Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti – Neoplastic Agents Market Drivers
1.6.2 Anti – Neoplastic Agents Market Restraints
1.6.3 Anti – Neoplastic Agents Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Anti – Neoplastic Agents Product and Services
2.1.4 Roche Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Anti – Neoplastic Agents Product and Services
2.2.4 Novartis Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Celgene
2.3.1 Celgene Details
2.3.2 Celgene Major Business
2.3.3 Celgene Anti – Neoplastic Agents Product and Services
2.3.4 Celgene Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Anti – Neoplastic Agents Product and Services
2.4.4 Bristol-Myers Squibb Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Anti – Neoplastic Agents Product and Services
2.5.4 Amgen Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Anti – Neoplastic Agents Product and Services
2.6.4 Johnson & Johnson Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Anti – Neoplastic Agents Product and Services
2.7.4 Pfizer Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Takeda
2.8.1 Takeda Details
2.8.2 Takeda Major Business
2.8.3 Takeda Anti – Neoplastic Agents Product and Services
2.8.4 Takeda Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Anti – Neoplastic Agents Product and Services
2.9.4 Eli Lilly Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Anti – Neoplastic Agents Product and Services
2.10.4 AstraZeneca Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Astellas
2.11.1 Astellas Details
2.11.2 Astellas Major Business
2.11.3 Astellas Anti – Neoplastic Agents Product and Services
2.11.4 Astellas Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Merck & Co.
2.12.1 Merck & Co. Details
2.12.2 Merck & Co. Major Business
2.12.3 Merck & Co. Anti – Neoplastic Agents Product and Services
2.12.4 Merck & Co. Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Anti – Neoplastic Agents Product and Services
2.13.4 Sanofi Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Bayer
2.14.1 Bayer Details
2.14.2 Bayer Major Business
2.14.3 Bayer Anti – Neoplastic Agents Product and Services
2.14.4 Bayer Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Biogen Idec
2.15.1 Biogen Idec Details
2.15.2 Biogen Idec Major Business
2.15.3 Biogen Idec Anti – Neoplastic Agents Product and Services
2.15.4 Biogen Idec Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Eisai
2.16.1 Eisai Details
2.16.2 Eisai Major Business
2.16.3 Eisai Anti – Neoplastic Agents Product and Services
2.16.4 Eisai Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Teva
2.17.1 Teva Details
2.17.2 Teva Major Business
2.17.3 Teva Anti – Neoplastic Agents Product and Services
2.17.4 Teva Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 Otsuka
2.18.1 Otsuka Details
2.18.2 Otsuka Major Business
2.18.3 Otsuka Anti – Neoplastic Agents Product and Services
2.18.4 Otsuka Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Merck KGaA
2.19.1 Merck KGaA Details
2.19.2 Merck KGaA Major Business
2.19.3 Merck KGaA Anti – Neoplastic Agents Product and Services
2.19.4 Merck KGaA Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 Ipsen
2.20.1 Ipsen Details
2.20.2 Ipsen Major Business
2.20.3 Ipsen Anti – Neoplastic Agents Product and Services
2.20.4 Ipsen Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.21 AbbVie
2.21.1 AbbVie Details
2.21.2 AbbVie Major Business
2.21.3 AbbVie Anti – Neoplastic Agents Product and Services
2.21.4 AbbVie Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.22 Gilead Sciences
2.22.1 Gilead Sciences Details
2.22.2 Gilead Sciences Major Business
2.22.3 Gilead Sciences Anti – Neoplastic Agents Product and Services
2.22.4 Gilead Sciences Anti – Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Anti – Neoplastic Agents Sales by Manufacturer
3.1 Global Anti – Neoplastic Agents Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anti – Neoplastic Agents Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anti – Neoplastic Agents
3.4 Market Concentration Rate
3.4.1 Top 3 Anti – Neoplastic Agents Manufacturer Market Share
3.4.2 Top 6 Anti – Neoplastic Agents Manufacturer Market Share
3.5 Global Anti – Neoplastic Agents Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anti – Neoplastic Agents Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti – Neoplastic Agents Market Size by Region
4.1.1 Global Anti – Neoplastic Agents Sales in Volume by Region (2016-2026)
4.1.2 Global Anti – Neoplastic Agents Revenue by Region (2016-2026)
4.2 North America Anti – Neoplastic Agents Revenue (2016-2026)
4.3 Europe Anti – Neoplastic Agents Revenue (2016-2026)
4.4 Asia-Pacific Anti – Neoplastic Agents Revenue (2016-2026)
4.5 South America Anti – Neoplastic Agents Revenue (2016-2026)
4.6 Middle East and Africa Anti – Neoplastic Agents Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anti – Neoplastic Agents Sales in Volume by Type (2016-2026)
5.2 Global Anti – Neoplastic Agents Revenue by Type (2016-2026)
5.3 Global Anti – Neoplastic Agents Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anti – Neoplastic Agents Sales in Volume by Application (2016-2026)
6.2 Global Anti – Neoplastic Agents Revenue by Application (2016-2026)
6.3 Global Anti – Neoplastic Agents Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anti – Neoplastic Agents Sales by Type (2016-2026)
7.2 North America Anti – Neoplastic Agents Sales by Application (2016-2026)
7.3 North America Anti – Neoplastic Agents Market Size by Country
7.3.1 North America Anti – Neoplastic Agents Sales in Volume by Country (2016-2026)
7.3.2 North America Anti – Neoplastic Agents Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti – Neoplastic Agents Sales by Type (2016-2026)
8.2 Europe Anti – Neoplastic Agents Sales by Application (2016-2026)
8.3 Europe Anti – Neoplastic Agents Market Size by Country
8.3.1 Europe Anti – Neoplastic Agents Sales in Volume by Country (2016-2026)
8.3.2 Europe Anti – Neoplastic Agents Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anti – Neoplastic Agents Sales by Type (2016-2026)
9.2 Asia-Pacific Anti – Neoplastic Agents Sales by Application (2016-2026)
9.3 Asia-Pacific Anti – Neoplastic Agents Market Size by Region
9.3.1 Asia-Pacific Anti – Neoplastic Agents Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anti – Neoplastic Agents Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anti – Neoplastic Agents Sales by Type (2016-2026)
10.2 South America Anti – Neoplastic Agents Sales by Application (2016-2026)
10.3 South America Anti – Neoplastic Agents Market Size by Country
10.3.1 South America Anti – Neoplastic Agents Sales in Volume by Country (2016-2026)
10.3.2 South America Anti – Neoplastic Agents Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti – Neoplastic Agents Sales by Type (2016-2026)
11.2 Middle East & Africa Anti – Neoplastic Agents Sales by Application (2016-2026)
11.3 Middle East & Africa Anti – Neoplastic Agents Market Size by Country
11.3.1 Middle East & Africa Anti – Neoplastic Agents Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anti – Neoplastic Agents Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anti – Neoplastic Agents Typical Distributors
12.3 Anti – Neoplastic Agents Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Anti - Neoplastic Agents Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anti - Neoplastic Agents Revenue by Application, (USD Million), 2021-2026
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Anti - Neoplastic Agents Product and Services
Table 6. Roche Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Anti - Neoplastic Agents Product and Services
Table 10. Novartis Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Celgene Basic Information, Manufacturing Base and Competitors
Table 12. Celgene Major Business
Table 13. Celgene Anti - Neoplastic Agents Product and Services
Table 14. Celgene Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 16. Bristol-Myers Squibb Major Business
Table 17. Bristol-Myers Squibb Anti - Neoplastic Agents Product and Services
Table 18. Bristol-Myers Squibb Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Amgen Basic Information, Manufacturing Base and Competitors
Table 20. Amgen Major Business
Table 21. Amgen Anti - Neoplastic Agents Product and Services
Table 22. Amgen Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Anti - Neoplastic Agents Product and Services
Table 26. Johnson & Johnson Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Major Business
Table 29. Pfizer Anti - Neoplastic Agents Product and Services
Table 30. Pfizer Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Takeda Basic Information, Manufacturing Base and Competitors
Table 32. Takeda Major Business
Table 33. Takeda Anti - Neoplastic Agents Product and Services
Table 34. Takeda Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 36. Eli Lilly Major Business
Table 37. Eli Lilly Anti - Neoplastic Agents Product and Services
Table 38. Eli Lilly Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 40. AstraZeneca Major Business
Table 41. AstraZeneca Anti - Neoplastic Agents Product and Services
Table 42. AstraZeneca Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Astellas Basic Information, Manufacturing Base and Competitors
Table 44. Astellas Major Business
Table 45. Astellas Anti - Neoplastic Agents Product and Services
Table 46. Astellas Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 48. Merck & Co. Major Business
Table 49. Merck & Co. Anti - Neoplastic Agents Product and Services
Table 50. Merck & Co. Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Sanofi Basic Information, Manufacturing Base and Competitors
Table 52. Sanofi Major Business
Table 53. Sanofi Anti - Neoplastic Agents Product and Services
Table 54. Sanofi Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Bayer Basic Information, Manufacturing Base and Competitors
Table 56. Bayer Major Business
Table 57. Bayer Anti - Neoplastic Agents Product and Services
Table 58. Bayer Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 60. Biogen Idec Major Business
Table 61. Biogen Idec Anti - Neoplastic Agents Product and Services
Table 62. Biogen Idec Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Eisai Basic Information, Manufacturing Base and Competitors
Table 64. Eisai Major Business
Table 65. Eisai Anti - Neoplastic Agents Product and Services
Table 66. Eisai Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Teva Basic Information, Manufacturing Base and Competitors
Table 68. Teva Major Business
Table 69. Teva Anti - Neoplastic Agents Product and Services
Table 70. Teva Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Otsuka Basic Information, Manufacturing Base and Competitors
Table 72. Otsuka Major Business
Table 73. Otsuka Anti - Neoplastic Agents Product and Services
Table 74. Otsuka Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 76. Merck KGaA Major Business
Table 77. Merck KGaA Anti - Neoplastic Agents Product and Services
Table 78. Merck KGaA Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Ipsen Basic Information, Manufacturing Base and Competitors
Table 80. Ipsen Major Business
Table 81. Ipsen Anti - Neoplastic Agents Product and Services
Table 82. Ipsen Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. AbbVie Basic Information, Manufacturing Base and Competitors
Table 84. AbbVie Major Business
Table 85. AbbVie Anti - Neoplastic Agents Product and Services
Table 86. AbbVie Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 88. Gilead Sciences Major Business
Table 89. Gilead Sciences Anti - Neoplastic Agents Product and Services
Table 90. Gilead Sciences Anti - Neoplastic Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Global Anti - Neoplastic Agents Sales by Manufacturer (2019-2021e) & (K Units)
Table 92. Global Anti - Neoplastic Agents Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 93. Market Position of Manufacturers in Anti - Neoplastic Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 94. Global Anti - Neoplastic Agents Production Capacity by Company, (K Units): 2020 VS 2021
Table 95. Head Office and Anti - Neoplastic Agents Production Site of Key Manufacturer
Table 96. Global Anti - Neoplastic Agents Sales by Region (2016-2021e) & (K Units)
Table 97. Global Anti - Neoplastic Agents Sales by Region (2021-2026) & (K Units)
Table 98. Global Anti - Neoplastic Agents Revenue by Region (2016-2021e) & (USD Million)
Table 99. Global Anti - Neoplastic Agents Revenue by Region (2021-2026) & (USD Million)
Table 100. Global Anti - Neoplastic Agents Sales by Type (2016-2021e) & (K Units)
Table 101. Global Anti - Neoplastic Agents Sales by Type (2021-2026) & (K Units)
Table 102. Global Anti - Neoplastic Agents Revenue by Type (2016-2021e) & (USD Million)
Table 103. Global Anti - Neoplastic Agents Revenue by Type (2021-2026) & (USD Million)
Table 104. Global Anti - Neoplastic Agents Price by Type (2016-2021e) & (USD/Unit)
Table 105. Global Anti - Neoplastic Agents Price by Type (2021-2026) & (USD/Unit)
Table 106. Global Anti - Neoplastic Agents Sales by Application (2016-2021e) & (K Units)
Table 107. Global Anti - Neoplastic Agents Sales by Application (2021-2026) & (K Units)
Table 108. Global Anti - Neoplastic Agents Revenue by Application (2016-2021e) & (USD Million)
Table 109. Global Anti - Neoplastic Agents Revenue by Application (2021-2026) & (USD Million)
Table 110. Global Anti - Neoplastic Agents Price by Application (2016-2021e) & (USD/Unit)
Table 111. Global Anti - Neoplastic Agents Price by Application (2021-2026) & (USD/Unit)
Table 112. North America Anti - Neoplastic Agents Sales by Country (2016-2021e) & (K Units)
Table 113. North America Anti - Neoplastic Agents Sales by Country (2021-2026) & (K Units)
Table 114. North America Anti - Neoplastic Agents Revenue by Country (2016-2021e) & (USD Million)
Table 115. North America Anti - Neoplastic Agents Revenue by Country (2021-2026) & (USD Million)
Table 116. North America Anti - Neoplastic Agents Sales by Type (2016-2021e) & (K Units)
Table 117. North America Anti - Neoplastic Agents Sales by Type (2021-2026) & (K Units)
Table 118. North America Anti - Neoplastic Agents Sales by Application (2016-2021e) & (K Units)
Table 119. North America Anti - Neoplastic Agents Sales by Application (2021-2026) & (K Units)
Table 120. Europe Anti - Neoplastic Agents Sales by Country (2016-2021e) & (K Units)
Table 121. Europe Anti - Neoplastic Agents Sales by Country (2021-2026) & (K Units)
Table 122. Europe Anti - Neoplastic Agents Revenue by Country (2016-2021e) & (USD Million)
Table 123. Europe Anti - Neoplastic Agents Revenue by Country (2021-2026) & (USD Million)
Table 124. Europe Anti - Neoplastic Agents Sales by Type (2016-2021e) & (K Units)
Table 125. Europe Anti - Neoplastic Agents Sales by Type (2021-2026) & (K Units)
Table 126. Europe Anti - Neoplastic Agents Sales by Application (2016-2021e) & (K Units)
Table 127. Europe Anti - Neoplastic Agents Sales by Application (2021-2026) & (K Units)
Table 128. Asia-Pacific Anti - Neoplastic Agents Sales by Region (2016-2021e) & (K Units)
Table 129. Asia-Pacific Anti - Neoplastic Agents Sales by Region (2021-2026) & (K Units)
Table 130. Asia-Pacific Anti - Neoplastic Agents Revenue by Region (2016-2021e) & (USD Million)
Table 131. Asia-Pacific Anti - Neoplastic Agents Revenue by Region (2021-2026) & (USD Million)
Table 132. Asia-Pacific Anti - Neoplastic Agents Sales by Type (2016-2021e) & (K Units)
Table 133. Asia-Pacific Anti - Neoplastic Agents Sales by Type (2021-2026) & (K Units)
Table 134. Asia-Pacific Anti - Neoplastic Agents Sales by Application (2016-2021e) & (K Units)
Table 135. Asia-Pacific Anti - Neoplastic Agents Sales by Application (2021-2026) & (K Units)
Table 136. South America Anti - Neoplastic Agents Sales by Country (2016-2021e) & (K Units)
Table 137. South America Anti - Neoplastic Agents Sales by Country (2021-2026) & (K Units)
Table 138. South America Anti - Neoplastic Agents Revenue by Country (2016-2021e) & (USD Million)
Table 139. South America Anti - Neoplastic Agents Revenue by Country (2021-2026) & (USD Million)
Table 140. South America Anti - Neoplastic Agents Sales by Type (2016-2021e) & (K Units)
Table 141. South America Anti - Neoplastic Agents Sales by Type (2021-2026) & (K Units)
Table 142. South America Anti - Neoplastic Agents Sales by Application (2016-2021e) & (K Units)
Table 143. South America Anti - Neoplastic Agents Sales by Application (2021-2026) & (K Units)
Table 144. Middle East & Africa Anti - Neoplastic Agents Sales by Country (2016-2021e) & (K Units)
Table 145. Middle East & Africa Anti - Neoplastic Agents Sales by Country (2021-2026) & (K Units)
Table 146. Middle East & Africa Anti - Neoplastic Agents Revenue by Country (2016-2021e) & (USD Million)
Table 147. Middle East & Africa Anti - Neoplastic Agents Revenue by Country (2021-2026) & (USD Million)
Table 148. Middle East & Africa Anti - Neoplastic Agents Sales by Type (2016-2021e) & (K Units)
Table 149. Middle East & Africa Anti - Neoplastic Agents Sales by Type (2021-2026) & (K Units)
Table 150. Middle East & Africa Anti - Neoplastic Agents Sales by Application (2016-2021e) & (K Units)
Table 151. Middle East & Africa Anti - Neoplastic Agents Sales by Application (2021-2026) & (K Units)
Table 152. Direct Channel Pros & Cons
Table 153. Indirect Channel Pros & Cons
Table 154. Anti - Neoplastic Agents Typical Distributors
Table 155. Anti - Neoplastic Agents Typical Customers
List of Figures
Figure 1. Anti - Neoplastic Agents Picture
Figure 2. Global Anti - Neoplastic Agents Sales Market Share by Type in 2020
Figure 3. Chemotherapy
Figure 4. Targeted Therapy
Figure 5. Immunotherapy
Figure 6. Hormonal Therapy (Biologic Therapy)
Figure 7. Others
Figure 8. Global Anti - Neoplastic Agents Sales Market Share by Application in 2020
Figure 9. Blood Cancer
Figure 10. Breast Cancer
Figure 11. Gastrointestinal Cancer
Figure 12. Prostate Cancer
Figure 13. Respiratory/Lung Cancer
Figure 14. Other Cancers
Figure 15. Global Anti - Neoplastic Agents Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 16. Global Anti - Neoplastic Agents Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. United States Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Canada Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Mexico Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Germany Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. France Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. United Kingdom Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Russia Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Italy Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. China Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Japan Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Korea Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. India Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Southeast Asia Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Australia Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Brazil Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Egypt Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Saudi Arabia Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. South Africa Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Turkey Anti - Neoplastic Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Global Anti - Neoplastic Agents Sales (2016-2026) & (K Units)
Figure 37. Global Anti - Neoplastic Agents Production Capacity (2016-2026) & (K Units)
Figure 38. Global Anti - Neoplastic Agents Production Capacity by Geographic Region: 2020 VS 2021
Figure 39. Anti - Neoplastic Agents Market Drivers
Figure 40. Anti - Neoplastic Agents Market Restraints
Figure 41. Anti - Neoplastic Agents Market Trends
Figure 42. Global Anti - Neoplastic Agents Sales Market Share by Manufacturer in 2020
Figure 43. Global Anti - Neoplastic Agents Revenue Market Share by Manufacturer in 2020
Figure 44. Anti - Neoplastic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 45. Top 3 Anti - Neoplastic Agents Manufacturer (Revenue) Market Share in 2020
Figure 46. Top 6 Anti - Neoplastic Agents Manufacturer (Revenue) Market Share in 2020
Figure 47. Global Anti - Neoplastic Agents Sales Market Share by Region (2016-2026)
Figure 48. Global Anti - Neoplastic Agents Revenue Market Share by Region (2016-2026)
Figure 49. North America Anti - Neoplastic Agents Revenue (2016-2026) & (USD Million)
Figure 50. Europe Anti - Neoplastic Agents Revenue (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Anti - Neoplastic Agents Revenue (2016-2026) & (USD Million)
Figure 52. South America Anti - Neoplastic Agents Revenue (2016-2026) & (USD Million)
Figure 53. Middle East & Africa Anti - Neoplastic Agents Revenue (2016-2026) & (USD Million)
Figure 54. Global Anti - Neoplastic Agents Sales Market Share by Type (2016-2026)
Figure 55. Global Anti - Neoplastic Agents Revenue Market Share by Type (2016-2026)
Figure 56. Global Anti - Neoplastic Agents Price by Type (2016-2026) & (USD/Unit)
Figure 57. Global Anti - Neoplastic Agents Sales Market Share by Application (2016-2026)
Figure 58. Global Anti - Neoplastic Agents Revenue Market Share by Application (2016-2026)
Figure 59. Global Anti - Neoplastic Agents Price by Application (2016-2026) & (USD/Unit)
Figure 60. North America Anti - Neoplastic Agents Sales Market Share by Country (2016-2026)
Figure 61. North America Anti - Neoplastic Agents Revenue Market Share by Country (2016-2026)
Figure 62. North America Anti - Neoplastic Agents Sales Market Share by Type (2016-2026)
Figure 63. North America Anti - Neoplastic Agents Sales Market Share by Application (2016-2026)
Figure 64. Europe Anti - Neoplastic Agents Sales Market Share by Country (2016-2026)
Figure 65. Europe Anti - Neoplastic Agents Revenue Market Share by Country (2016-2026)
Figure 66. Europe Anti - Neoplastic Agents Sales Market Share by Type (2016-2026)
Figure 67. Europe Anti - Neoplastic Agents Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Anti - Neoplastic Agents Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Anti - Neoplastic Agents Revenue Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Anti - Neoplastic Agents Sales Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Anti - Neoplastic Agents Sales Market Share by Application (2016-2026)
Figure 72. South America Anti - Neoplastic Agents Sales Market Share by Country (2016-2026)
Figure 73. South America Anti - Neoplastic Agents Revenue Market Share by Country (2016-2026)
Figure 74. South America Anti - Neoplastic Agents Sales Market Share by Type (2016-2026)
Figure 75. South America Anti - Neoplastic Agents Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Anti - Neoplastic Agents Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Anti - Neoplastic Agents Revenue Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Anti - Neoplastic Agents Sales Market Share by Type (2016-2026)
Figure 79. Middle East & Africa Anti - Neoplastic Agents Sales Market Share by Application (2016-2026)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界の植物性抗がん剤市場 2021：企業別、地域別、種類・用途別 The Plant Sources Anti Cancer Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…- 世界の固化防止剤市場 2021：企業別、地域別、種類・用途別 The Anti-caking Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界の食品用固化防止剤市場 2021：企業別、地域別、種類・用途別 The Food Anti-caking Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の肥料固結防止剤市場 2021：企業別、地域別、種類・用途別 The Fertilizer Anti-Caking Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の小分子標的がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Cancer Therapy Market The global Small Molecule Targeted Cancer Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…